Caplin Point Laboratories Ltd is a high-risk pharmaceutical company based in India. Specializing in manufacturing and marketing a wide range of pharmaceutical products, including tablets, capsules, injections, and more. With a focus on Antibiotics, Nsaids, Ophthalmics, Pain Management, and Antiulcers, their products have a strong presence in Latin American and African markets. The company has an ESG score of 33.6, emphasizing its commitment to environmental sustainability and governance.